美国高危局限性前列腺癌男性的当代管理
基于美国国家癌症数据库2004-2013年数据,纳入127391例高危局限性前列腺癌男性,评估初始管理趋势。根治性前列腺切除术使用率从2004年26%升至2013年42%(校正RR 1.51,95%CI 1.42-1.60,P<0.001),外照射放疗从49%降至42%(P<0.001);至2013年两者使用率相近。非裔美国男性、老年男性及无私人保险者接受根治性前列腺切除术的可能性较低。
要点
- 2004至2013年高危局限性前列腺癌根治性前列腺切除术使用率从26%升至42%。
- 同期外照射放疗使用率从49%降至42%,至2013年与根治性前列腺切除术相近。
- 非裔美国男性、老年男性及无私人保险者接受根治性前列腺切除术的可能性较低。
核心结论
- 2004至2013年高危局限性前列腺癌接受根治性前列腺切除术的可能性大幅增加,至2013年根治性前列腺切除术与外照射放疗的使用率相近。
- 非裔美国男性、老年男性及无私人保险者接受根治性前列腺切除术的可能性较低。
研究设计与样本
- 基于美国国家癌症数据库2004-2013年数据,采用美国国家综合癌症网络标准识别所有高危局限性前列腺癌男性。
- 评估初始管理的时间趋势,并使用多因素logistic回归分析与接受根治性前列腺切除术相关的人口学和临床因素。
主要发现
- 共识别127391例高危局限性前列腺癌男性。
- 根治性前列腺切除术使用率从2004年26%升至2013年42%(校正RR 1.51,95%CI 1.42-1.60,P<0.001)。
- 外照射放疗使用率从2004年49%降至2013年42%(P<0.001)。
- 非裔美国男性接受根治性前列腺切除术的未校正率为28%,白人男性为37%;校正RR 0.69(95%CI 0.66-0.72,P<0.001)。
- 年龄与接受根治性前列腺切除术的可能性呈负相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgery and radiation-based therapies are standard management options for men with clinically localized high-risk prostate cancer (PCa). Contemporary patterns of care are unknown. We hypothesize the use of surgery has steadily increased in more recent years. METHODS: Using the National Cancer Data Base for 2004-2013, all men diagnosed with high-risk localized PCa were identified using National Comprehensive Cancer Network criteria. Temporal trends in initial management were assessed. Multivariable logistic regression was used to evaluate demographic and clinical factors associated with undergoing radical prostatectomy (RP). RESULTS: In total, 127 391 men were identified. Use of RP increased from 26% in 2004 to 42% in 2013 (adjusted risk ratio (RR) 1.51, 95% CI 1.42-1.60, P<0.001), while external beam radiation therapy (EBRT) decreased from 49% to 42% (P<0.001). African American men had lower odds of undergoing RP (unadjusted rate of 28%, adjusted RR 0.69, 95% CI 0.66-0.72, <0.001) compared to White men (37%). Age was inversely associated with likelihood of receiving RP. Having private insurance was significantly associated with the increased use of RP (vs Medicare, adjusted odds ratio 1.04, 95% CI 1.01-1.08, P=0.015). Biopsy Gleason scores 8-10 with and without any primary Gleason 5 pattern were associated with decreased odds of RP (vs Gleason score ⩽6, both P<0.001). Academic and comprehensive cancer centers were more likely to perform RP compared to community hospitals (both P<0.001). CONCLUSION: The likelihood of receiving RP for high-risk PCa dramatically increased from 2004 to 2013. By 2013, the use of RP and EBRT were similar. African American men, elderly men and those without private insurance were less likely to receive RP.
引用
- Weiner AB, Matulewicz RS, Schaeffer EM, et al. Contemporary management of men with high-risk localized prostate cancer in the United States. Prostate Cancer Prostatic Dis. 2017. PMID: 28631720. doi:10.1038/pcan.2017.5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。